Frontlight ResearchEarly access
Trial site
Military Medical Academy
- 6running trials
- 6closed trials
The trials here
What the 12 trials at this site are about, from their registry records.
- Conditions
- COPD3 trials
- CIDP (chronic inflammatory demyelinating polyneuropathy)2 trials
- Lupus (SLE)2 trials
- Multiple sclerosis1 trial
- Parkinson disease1 trial
- Rheumatoid arthritis1 trial
- Stroke1 trial
- Systemic sclerosis (scleroderma)1 trial
- Phase
- Phase 37 trials
- Phase 25 trials
- Status
- Completed6 trials
- Recruiting3 trials
- Active, not recruiting2 trials
- Not yet recruiting1 trial
- Lead sponsor
- Chiesi Farmaceutici S.p.A.3 trials
- Boehringer Ingelheim2 trials
- AbbVie1 trial
- Alumis Inc.1 trial
- argenx1 trial
- and 4 more
Running trials
Recruiting
A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
Recruiting
Recruiting
Active, not recruiting
Phase 2 Placebo-controlled Study to Assess the Safety, Efficacy, and PK of ESK-001 in SLE
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- CIDP (chronic inflammatory demyelinating polyneuropathy)1 recruiting
- Lupus (SLE)1 recruiting
- Rheumatoid arthritis1 recruiting
- Systemic sclerosis (scleroderma)1 recruiting
Closed trials
Completed
A Phase 2b Study to Assess the Safety and tolerability of Batoclimab in Patients with CIDP
Completed
Completed
Completed
The efficacy and safety of two doses of CHF6001 DPI as add-on to maintenance COPD triple therapy
Completed
Completed
Site data: EU CTIS (euclinicaltrials.eu)Updated 12 Nov 2026